Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits

被引:54
作者
Pfister, Lukas A. [1 ]
Alther, Eva [1 ]
Papaloizos, Michael L. [2 ]
Merkle, Hans P. [1 ]
Gander, Bruno [1 ]
机构
[1] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland
[2] Ctr Hand Surg & Therapy, Geneva, Switzerland
关键词
NGF; release kinetics; nerve conduit; nerve regeneration;
D O I
10.1016/j.ejpb.2008.01.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The delivery kinetics of growth factors has been suggested to play an important role in the regeneration of peripheral nerves following axotomy. In this context, we designed a nerve conduit (NC) with adjustable release kinetics of nerve growth factor (NGF). A multi-ply system was designed where NC consisting of a polyelectrolyte alginate/chitosan complex was coated with layers of poly(lactide-co-glycolide) (PLGA) to control the release of embedded NGF. Prior to assessing the in vitro NGF release from NC, various release test media, with and without stabilizers for NGF, were evaluated to ensure adequate quantification of NGF by ELISA. Citrate (pH 5.0) and acetate (pH 5.5) buffered saline solutions containing 0.05% Tween 20 yielded the most reliable results for ELISA active NGF. The in vitro release experiments revealed that the best results in terms of reproducibility and release control were achieved when the NGF was embedded between two PLGA layers and the ends of the NC tightly sealed by the PLGA coatings. The release kinetics could be efficiently adjusted by accommodating NGF at different radial locations within the NC. A sustained release of bioactive NGF in the low nanogram per day range was obtained for at least 15 days. In conclusion, the developed multi-ply NGF loaded NC is considered a suitable candidate for future implantation studies to gain insight into the relationship between local growth factor availability and nerve regeneration. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:563 / 572
页数:10
相关论文
共 31 条
  • [21] Gelatin-based hydrogel for vascular endothelial growth factor release in peripheral nerve tissue engineering
    Gnavi, S.
    di Blasio, L.
    Tonda-Turo, C.
    Mancardi, A.
    Primo, L.
    Ciardelli, G.
    Gambarotta, G.
    Geuna, S.
    Perroteau, I.
    [J]. JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2017, 11 (02) : 459 - 470
  • [22] Nano-Patterned Poly-ε-caprolactone with Controlled Release of Retinoic Acid and Nerve Growth Factor for Neuronal Regeneration
    Teo, K. K.
    Yim, Evelyn K. F.
    [J]. 13TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING, VOLS 1-3, 2009, 23 (1-3): : 1348 - +
  • [23] Fine tuning of insulin secretion by release of nerve growth factor from mouse and human islet β-cells
    Pingitore, Attilio
    Caroleo, Maria Cristina
    Cione, Erika
    Castanera Gonzalez, Ramon
    Huang, Guo Cai
    Persaud, Shanta J.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2016, 436 (0C) : 23 - 32
  • [24] Controlled release of nerve growth factor from sandwiched poly(L-lactide-co-glycolide) films for the application in neural tissue engineering
    Khang, G
    Jeon, EK
    Rhee, JM
    [J]. MACROMOLECULAR RESEARCH, 2003, 11 (05) : 334 - 340
  • [25] Controlled release of nerve growth factor from sandwiched poly(L-lactide-co-glycolide) films for the application in neural tissue engineering
    Gilson Khang
    Eun Kyung Jeon
    John M. Rhee
    Ilwoo Lee
    Sang Jin Lee
    Hai Bang Lee
    [J]. Macromolecular Research, 2003, 11 : 334 - 340
  • [26] NERVE GROWTH-FACTOR AND K-252A INCREASE CATECHOLAMINE RELEASE FROM PC12 CELLS
    NIKODIJEVIC, B
    CREVELING, CR
    KOIZUMI, S
    GUROFF, G
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1990, 26 (03) : 288 - 295
  • [27] Periurethral Injection of Autologous Adipose-Derived Stem Cells with Controlled-Release Nerve Growth Factor for the Treatment of Stress Urinary Incontinence in a Rat Model
    Zhao, Weiming
    Zhang, Cheng
    Jin, Chengjun
    Zhang, Zijian
    Kong, Deling
    Xu, Wanhai
    Xiu, Youcheng
    [J]. EUROPEAN UROLOGY, 2011, 59 (01) : 155 - 163
  • [28] Nerve growth factor-and neurotrophin-3-induced changes in nociceptive threshold and the release of substance P from the rat isolated spinal cord
    Malcangio, M
    Garrett, NE
    Cruwys, S
    Tomlinson, DR
    [J]. JOURNAL OF NEUROSCIENCE, 1997, 17 (21) : 8459 - 8467
  • [29] Activation of A1 adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100β protein from cultured astrocytes
    Ciccarelli, R
    Di Iorio, P
    Bruno, V
    Battaglia, G
    D'Alimonte, I
    D'Onofrio, M
    Nicoletti, F
    Caciagli, F
    [J]. GLIA, 1999, 27 (03) : 275 - 281
  • [30] Therapeutic Effect of Controlled Release of Dual Growth Factor Using Heparin-Pluronic Hydrogel/Gelatin-Poly (Ethylene Glycol)-Tyramine Hydrogel System in a Rat Model of Cavernous Nerve Injury
    Jung, Ae Ryang
    Park, Yong Hyun
    Jeon, Seung Hwan
    Kim, Ga Eun
    Kim, Mee Young
    Son, Joo Young
    Ha, U-Syn
    Hong, Sung-Hoo
    Kim, Sae Woong
    Park, Ki Dong
    Lee, Ji Youl
    [J]. TISSUE ENGINEERING PART A, 2018, 24 (23-24) : 1705 - 1714